Additionally, the common comorbidities of psoriasis include insulin resistance, obesity, and metabolic syndrome, in which RBP-4 has been found to be involved; hence, it is rather complicated to expound the specific actions of RBP-4 in psoriasis with current data. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.